Skip to main content

Acrivastine / pseudoephedrine Side Effects

Medically reviewed by Drugs.com. Last updated on May 9, 2022.

Applies to acrivastine/pseudoephedrine: oral capsule

Nervous system

Very common (10% or more): Headache (19%), somnolence (12%)

Common (1% to 10%): Dizziness[Ref]

Gastrointestinal

Common (1% to 10%): Dry mouth, nausea, dyspepsia[Ref]

Hypersensitivity

Postmarketing reports: Serious hypersensitivity reactions (anaphylaxis, angioedema, bronchospasm, erythema multiforme)[Ref]

Psychiatric

Common (1% to 10%): Insomnia, nervousness

Genitourinary

Common (1% to 10%): Dysmenorrhea

Respiratory

Common (1% to 10%): Pharyngitis, cough increase

Other

Common (1% to 10%): Asthenia

References

1. "Product Information. Semprex-D (acrivastine-pseudoephedrine)." Endo Laboratories LLC (2001):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.